Company Filing History:
Years Active: 2022-2025
Title: Richard Unwin: Innovator in Polypeptide Technology
Introduction
Richard Unwin is a notable inventor based in Manchester, GB. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides. With a total of 2 patents to his name, Unwin's work focuses on innovative solutions for treating and preventing various diseases.
Latest Patents
Unwin's latest patents include the C3B binding polypeptide. This invention discloses polypeptides that comprise a C3b binding region, along with nucleic acids and vectors encoding such polypeptides. Additionally, it covers cells and compositions that include these polypeptides. The patents also detail various uses and methods for employing these polypeptides in the treatment and prevention of diseases and conditions.
Career Highlights
Richard Unwin is associated with Complement Therapeutics Limited, where he applies his expertise in polypeptide technology. His work at the company has positioned him as a key player in the biotechnology sector, contributing to advancements that have the potential to improve health outcomes.
Collaborations
Unwin collaborates with notable colleagues, including Paul Bishop and Simon Clark. Their combined efforts in research and development have fostered a collaborative environment that enhances innovation within their field.
Conclusion
Richard Unwin's contributions to polypeptide technology exemplify the impact of innovative thinking in biotechnology. His patents and collaborations reflect a commitment to advancing medical science and improving patient care.